Our unique process, paired withinnovation and continued improvement and evolution, puts us at the forefront.
Bioengineered Blood Vessel Aims to Revolutionize Dialysis Access
Humacyte Appoints Jeffrey Lawson MD, PhD as President and Chief Executive Officer
Fresenius Medical Care and Humacyte announce strategic global partnership supported by a $150M equity investment
Humacyte Closes $75 Million Series C Financing
From lower costs to fewer operations, HAVs may offer critical benefits.
With each year, we’ve movedcloser to lifesaving treatments.